STOCK TITAN

Penumbra, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference

(Neutral)
(Neutral)
Tags
conferences

Rhea-AI Summary

Penumbra, Inc. (NYSE: PEN) will present at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021, at 11:00am ET / 8:00am PT. The event will showcase the company's innovative healthcare therapies aimed at addressing significant medical needs. Interested parties can access a webcast of the presentation via the investors' section of Penumbra's website, available for two weeks post-event. Penumbra operates primarily in the US, Europe, Canada, and Australia, focusing on cutting-edge products in the healthcare sector.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – PEN

+0.89%
+0.89% Session move

In the trading session that priced this news, PEN gained 0.89%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ALAMEDA, Calif., July 28, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 41st Annual Growth Conference on Wednesday, August 11, 2021.

Event:

Canaccord Genuity 41st Annual Growth Conference

Date:

Wednesday, August 11, 2021

Time:

11:00am ET /8:00am PT

A webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com.  The webcast will be available on the company's website for at least two weeks following the event.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals and healthcare providers primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-canaccord-genuity-41st-annual-growth-conference-301341371.html

SOURCE Penumbra, Inc.

FAQ

When is Penumbra's presentation at the Canaccord Genuity Growth Conference?

Penumbra's presentation at the Canaccord Genuity 41st Annual Growth Conference is scheduled for August 11, 2021.

What time will Penumbra's presentation take place?

The presentation will take place at 11:00am ET / 8:00am PT.

How can I watch the Penumbra presentation?

You can watch the Penumbra presentation by accessing the webcast available in the investors' section of their website.

Is the Penumbra presentation available for later viewing?

Yes, the webcast of Penumbra's presentation will be available for at least two weeks after the event.

What is the focus of Penumbra's product portfolio?

Penumbra focuses on innovative therapies designed to address challenging medical conditions with significant unmet needs.